United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read Healthcare Industry News MyHealthChecked (AIM: MHC) stock drops 22.5% as Concepta sale to Boots UK turns firm into cash shell MyHealthChecked’s shares plunge 22.5% after selling Concepta Diagnostics to Boots UK for £2.375m. Find out how this move changes its business model and outlook. byVenkateshOctober 15, 2025